Pheochromocytoma, Fulminant Heart Failure, and a Phenylephrine Challenge. The Perioperative Management of Adrenalectomy in a Jehovah’s Witness Patient: A Case Report
, , et
13 nov. 2021
À propos de cet article
Catégorie d'article: Case report
Publié en ligne: 13 nov. 2021
Pages: 55 - 60
Reçu: 06 avr. 2021
Accepté: 10 oct. 2021
DOI: https://doi.org/10.2478/jccm-2021-0038
Mots clés
© 2022 Sarah A. Bachman, Ryan S. Peterson, Peter S. Burrage, Leigh C Hickerson, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig. 1
Perioperative goals for pheochromocytoma, stress cardiomyopathy, and acute decompensated heart failure [19]
| Pheochromocytoma | Stress Cardiomyopathy | ADHF | |
|---|---|---|---|
| Preoperative | Alpha Blockade | Afterload reduction | Afterload reduction |
| Optimization | Antiarrhythmic | Antiarrhythmic | Antiarrhythmic/ICD |
| Volume loading | Diuretics | Diuretics | |
| Beta Blockade | Beta blockade/ACEI (chronic | Beta blockade/ACEI (chronic | |
| stage/recovery) MCS | stage/recovery) MCS | ||
| Intraoperative | Afterload reduction Vol- | Afterload reduction | Maintain cardiac output |
| Hemodynamic Goals | ume resuscitation | Avoid volume overload | Avoid volume overload |
| Expected Recovery | 10 days - 6 weeks | 1-4 weeks | Chronic, progressive |